FR8225M - - Google Patents

Info

Publication number
FR8225M
FR8225M FR160408A FR160408A FR8225M FR 8225 M FR8225 M FR 8225M FR 160408 A FR160408 A FR 160408A FR 160408 A FR160408 A FR 160408A FR 8225 M FR8225 M FR 8225M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR160408A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM Delft BV
Original Assignee
Koninklijke Nederlandsche Gist en Spiritusfabriek BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Nederlandsche Gist en Spiritusfabriek BV filed Critical Koninklijke Nederlandsche Gist en Spiritusfabriek BV
Application granted granted Critical
Publication of FR8225M publication Critical patent/FR8225M/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F21LIGHTING
    • F21VFUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR
    • F21V17/00Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages
    • F21V17/10Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening
    • F21V17/20Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening by toggle-action levers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR160408A 1968-01-23 1968-07-24 Expired FR8225M (US08017720-20110913-C00001.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB358768 1968-01-23

Publications (1)

Publication Number Publication Date
FR8225M true FR8225M (US08017720-20110913-C00001.png) 1970-09-28

Family

ID=9761163

Family Applications (2)

Application Number Title Priority Date Filing Date
FR160408A Expired FR8225M (US08017720-20110913-C00001.png) 1968-01-23 1968-07-24
FR6900649A Pending FR2000571A1 (US08017720-20110913-C00001.png) 1968-01-23 1969-01-16

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR6900649A Pending FR2000571A1 (US08017720-20110913-C00001.png) 1968-01-23 1969-01-16

Country Status (12)

Country Link
US (1) US3557162A (US08017720-20110913-C00001.png)
AT (1) AT292929B (US08017720-20110913-C00001.png)
BE (1) BE726981A (US08017720-20110913-C00001.png)
CH (1) CH511822A (US08017720-20110913-C00001.png)
DE (1) DE1903118A1 (US08017720-20110913-C00001.png)
DK (1) DK120234B (US08017720-20110913-C00001.png)
ES (1) ES362475A1 (US08017720-20110913-C00001.png)
FR (2) FR8225M (US08017720-20110913-C00001.png)
GB (1) GB1227992A (US08017720-20110913-C00001.png)
IT (1) IT1036015B (US08017720-20110913-C00001.png)
NL (1) NL162083C (US08017720-20110913-C00001.png)
SE (1) SE339828B (US08017720-20110913-C00001.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1033042B (it) * 1970-03-14 1979-07-10 Luso Farmaco Inst Desametazone 17 valerato e processi per la sua preparazione
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
DE3442527A1 (de) * 1983-11-23 1985-05-30 Bösha GmbH & Co KG, 4780 Lippstadt Langfeldleuchte fuer den einsatz in schlagwetter- und explosionsgeschuetzten bereichen
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
BRPI0113042B8 (pt) 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
BR0209271A (pt) * 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
US20040248867A1 (en) * 2001-06-12 2004-12-09 Keith Biggadike Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
UA116622C2 (uk) 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Also Published As

Publication number Publication date
CH511822A (de) 1971-08-31
DE1903118A1 (de) 1969-08-07
SE339828B (US08017720-20110913-C00001.png) 1971-10-25
NL6901024A (US08017720-20110913-C00001.png) 1969-07-25
NL162083C (nl) 1980-04-15
NL162083B (nl) 1979-11-15
US3557162A (en) 1971-01-19
BE726981A (US08017720-20110913-C00001.png) 1969-07-16
AT292929B (de) 1971-09-10
IT1036015B (it) 1979-10-30
DK120234B (da) 1971-05-03
FR2000571A1 (US08017720-20110913-C00001.png) 1969-09-12
ES362475A1 (es) 1970-12-01
GB1227992A (US08017720-20110913-C00001.png) 1971-04-15

Similar Documents

Publication Publication Date Title
AU428130B2 (US08017720-20110913-C00001.png)
AU5184069A (US08017720-20110913-C00001.png)
FR8225M (US08017720-20110913-C00001.png)
AU6168869A (US08017720-20110913-C00001.png)
AU6171569A (US08017720-20110913-C00001.png)
AU429879B2 (US08017720-20110913-C00001.png)
AU4811568A (US08017720-20110913-C00001.png)
AU4744468A (US08017720-20110913-C00001.png)
AU479894A (US08017720-20110913-C00001.png)
AU463027A (US08017720-20110913-C00001.png)
BE709138A (US08017720-20110913-C00001.png)
BE709119A (US08017720-20110913-C00001.png)
BE709095A (US08017720-20110913-C00001.png)
BE708951A (US08017720-20110913-C00001.png)
BE708933A (US08017720-20110913-C00001.png)
BE708888A (US08017720-20110913-C00001.png)
BE642636A (US08017720-20110913-C00001.png)
BE630165A (US08017720-20110913-C00001.png)
BE581157A (US08017720-20110913-C00001.png)
BE709301A (US08017720-20110913-C00001.png)
BE709319A (US08017720-20110913-C00001.png)
AU5758767A (US08017720-20110913-C00001.png)
BE709496A (US08017720-20110913-C00001.png)
BE709415A (US08017720-20110913-C00001.png)
BE709435A (US08017720-20110913-C00001.png)